Pharma Co. Inks $7M Deal To End Investor's Cancer Study Suit
A Spectrum Pharmaceuticals Inc. investor has asked a New York federal court to approve a $7 million deal resolving class action claims alleging the drugmaker overstated its regulatory prospects for winning...To view the full article, register now.
Already a subscriber? Click here to view full article